Search clinical trials for: split dose insulin glargine

Total 657 results

Geropharm

Completed

Efficacy and Safety of Insulin RinGlar® Compared to Lantus® SoloStar® in Type 1 Diabetes Mellitus Patients

Diabetes Mellitus | Diabetes Mellitus, Type 1

Russian Federation
HyGIeaCare, Inc.

Withdrawn

HyGIeaCare Prep vs Split-dose PEG Prep Prior to Colonoscopy

Colonoscopy
Eli Lilly and Company

Completed

A Study of Dulaglutide (LY2189265) in Participants With Type II Diabetes (AWARD-9)

Diabetes Mellitus, Type 2

United States, Czechia, Hungary, Italy, Puerto Rico, Spain, United Kingdom
John H. Stroger Hospital

Completed

Combination of Sulfonylureas and Insulin Glargine Outpatient Therapy for Unstable Diabetes and Impending DKA

Type 2 Diabetes

United States
University Hospital, Montpellier
Université Montpellier

Completed

Impact of Food Carbohydrate and Insulin Dose Computing by on Smart Phone on Glucose Control in Patients With Diabetes (GLUCAL)

Type 1 Diabetes

France
RenJi Hospital

Unknown

The Initial Assessment of Daily Insulin Dose in Newly Diagnosed Type 2 Diabetes

Type 2 Diabetes.

China
Novo Nordisk A/S

Completed

Comparing the Efficacy and Safety of NN1250 Once Daily When Titrated Using 2 Different Algorithms in Insulin naïve Subjects With Type 2 Diabetes Mellitus (BEGIN™)

Diabetes Mellitus, Type 2 | Diabetes

United States, Spain, Finland, Germany
Laniado Hospital

Terminated

Evaluation of Lixisenatide Efficacy in Diabetes Mellitus Type 2 With Failure of Other GLP-1 Analog

Diabetes Mellitus Type 2

Israel
Merck Sharp & Dohme LLC

Completed

Single Ascending Dose Study of MK-1092 in Healthy Participants and in Participants With Type 1 and Type 2 Diabetes Mellitus (MK-1092-001)

Type 2 Diabetes Mellitus | Type 1 Diabetes Mellitus

United States
Eli Lilly and Company
Alkermes, Inc.

Completed

Compare Two Dosing Algorithms in Insulin-Naive Patients With Type 2 Diabetes Mellitus

Diabetes Mellitus, Type 2

Puerto Rico, United States, Spain, India, Belgium, Argentina, Austria, France, Mexico
Albert Einstein College of Medicine
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

New Onset Type 1 Diabetes: Role of Exenatide

Type 1 Diabetes

United States
Northumbria University

Completed

Insulin Dose Adjustments for Meals Differing in Fat Content in T1DM

Low Fat Meal - Unadjusted Insulin Dose | High Fat Meal - Unadjusted Insulin Dose | High Fat Meal - Adjusted Insulin Dose +30 Percent | High Fat Meal - Adjusted Insulin Dose +Split Dose
Eli Lilly and Company

Completed

A Study Comparing Insulin Peglispro With Insulin Glargine as Basal Insulin Treatment

Type 2 Diabetes Mellitus

Japan, Taiwan, Korea, Republic of
Rabin Medical Center

Unknown

Safety and Efficiency of Linagliptin (Trajenta) in the Setting of Internal Medicine Department

DM2
Population Health Research Institute
Merck Sharp & Dohme LLC

Completed

Remission Evaluation of a Metabolic Intervention in Type 2 Diabetes With Sitagliptin (REMIT-Sita)

Type 2 Diabetes Mellitus

Canada
Ain Shams University

Completed

Long Acting Insulin Versus Multiple Dose Regimen for Control of Gestational Diabetes Mellitus

Long Acting Insulin in Control of Gestational Diabetes Mellitus

Egypt
University Hospital, Angers

Unknown

Evaluation of Interests of FIT Therapy on Diabetics Children Insulin-dependent (DIABFIT)

Diabetes Insulin Dependent

France
Sanofi

Completed

Effect of Lixisenatide on Postprandial Plasma Glucose Compared to Sitagliptin in Combination With Insulin Glargine

Type 2 Diabetes Mellitus

Japan
Merck Sharp & Dohme LLC

Completed

A Study to Evaluate the Safety, Tolerability, and Efficacy of the Addition of Omarigliptin (MK-3102) to Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin Therapy (MK-3102-024)

Type 2 Diabetes Mellitus
Eli Lilly and Company

Completed

A Study of LY2963016 Compared to Lantus® in Adult Chinese Participants With Type 2 Diabetes Mellitus

Type 2 Diabetes

China
Sanofi

Completed

Insulin Glargine in Type 2 Diabetic Patients (TARGET)

Diabetes Mellitus, Type 2

China
Portuguese Oncology Institute, Coimbra

Completed

Effect of Adding Simethicone to Split-dose Polyethylene Glycol for Bowel Preparation in a Screening Colonoscopy Setting

Colonic Neoplasms | Colo-rectal Cancer

Portugal
Stallergenes Greer

Completed

Dose Ranging Study of SLIT Tablets of House Dust Mite Allergen Extracts (HDM) in Adults With HDM-associated Allergic Asthma

Asthma | House Dust Mite Allergy

France, Germany, Poland
Inje University

Unknown

Comparison of Same-day 2 Sachets Picosulfate Versus High Volume PEG for Afternoon Colonoscopy (SP2HP)

Colonoscopy

Korea, Republic of
Emory University

Completed

Exenatide Inpatient Trial: A Randomized Controlled Pilot Trial on the Safety and Efficacy of Exenatide (Byetta®) Therapy for the Inpatient Management of Patients With Type 2 Diabetes

Type 2 Diabetes

United States
University of Texas Southwestern Medical Center
Novo Nordisk A/S

Terminated

Duration of The Honeymoon Phase of Type 1 Diabetes: A Comparison of Insulins Detemir, Glargine and NPH

Type 1 Diabetes

United States
Lexicon Pharmaceuticals
Sanofi

Completed

Efficacy and Safety of Sotagliflozin Versus Placebo in Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control While Taking Insulin Alone or With Other Oral Antidiabetic Agents (SOTA-INS)

Type 2 Diabetes Mellitus

United States, Bulgaria, Canada, Czechia, France, Hungary, Slovakia, United Kingdom
Baylor College of Medicine

Completed

Lantus in the Treatment of Type 1 Diabetes Children

Type 1 Diabetes

United States
Shanghai Cell Therapy Group Co.,Ltd
Shanghai Mengchao Cancer Hospital

Not yet recruiting

The Exploratory Study on the Nicotinamide Mononucleotide (Vital NAD ) to Promote the Rejuvenation of the Peripheral Blood Immune Cells of Adults.

Enhance Immune Function

China
Inova Health Care Services

Withdrawn

The Inova Type 2 Diabetes Mellitus Study (InovaDM2)

Diabetes, Type 2

United States
University of North Carolina, Chapel Hill
National Center for Complementary and Integrative Health (NCCIH)

Completed

A Study of Sublingual Immunotherapy in Peanut-allergic Children (SLB)

Food Hypersensitivity

United States
Linda Siminerio
Sanofi

Terminated

My Dose Coach Mobile App to Support Insulin Titration and Maintenance

Diabetes Mellitus Type 2 - Insulin-Treated

United States
McGill University Health Centre/Research Institute...

Recruiting

Application of High-dose Insulin Therapy to Improve Liver Function and Regeneration

Liver Dysfunction | Liver Metastasis Colon Cancer | Liver Regeneration

Canada
Merck Sharp & Dohme LLC

Completed

Randomized Sitagliptin Withdrawal Study (MK-0431-845)

Type 2 Diabetes Mellitus
Sanofi

Completed

Optimal Oral Hypoglycaemic Agents (OHA) for Combination With Insulin Glargine (Sulfonylurea vs. Metformin)

Type 2 Diabetes Mellitus

Korea, Republic of
Hospital de Clinicas de Porto Alegre

Completed

Reusing Needles for Subcutaneous Insulin Injection in Patients With Type 2 Diabetes

Diabetes Mellitus, Type 2

Brazil
Federico II University

Completed

Glycaemic Load and Pre-meal Insulin Doses in Type 1 Diabetes Patients (GLUT)

Type 1 Diabetes
AstraZeneca

Completed

A 24-week Open-Label, Phase 3b Trial With a 28-week Extension to Evaluate the Efficacy and Safety of Saxagliptin Co-administered With Dapagliflozin Compared to Insulin Glargine in Subjects withType 2 Diabetes Who Have Glycemic Control on Metformin

Type 2 Diabetes Mellitus

United States, Poland, Mexico, Hungary, Spain, Romania, South Africa, Denmark, Czechia, Sweden
Sanofi Pasteur, a Sanofi Company

Terminated

Study to Evaluate the Effectiveness of a High-Dose Quadrivalent Influenza Vaccine (QIV-HD) Compared to a Standard-Dose Quadrivalent Influenza Vaccine (QIV-SD) in Adults 65 Years of Age and Older

Influenza (Healthy Volunteers)

Finland
Eli Lilly and Company

Completed

A Study in Participants With Type 2 Diabetes Mellitus (AWARD-2) (AWARD-2)

Diabetes Mellitus, Type 2

Argentina, India, Australia, Spain, Taiwan, France, Canada, Hungary, Mexico, Croatia, Korea, Republic of, Poland, Greece, Belgium, Brazil, Italy, Czech Republic, Romania, Slovakia, Sweden
Eli Lilly and Company

Completed

A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes on Metformin With or Without Sulfonylurea (SURPASS-AP-Combo)

Type 2 Diabetes

China, Australia, Korea, Republic of, India
Eli Lilly and Company

Completed

A Study of Tirzepatide (LY3298176) Once a Week Versus Insulin Glargine Once a Day in Participants With Type 2 Diabetes and Increased Cardiovascular Risk (SURPASS-4)

Type 2 Diabetes Mellitus

Russian Federation, United States, Puerto Rico, Australia, Taiwan, Israel, Spain, Canada, Greece, Argentina, Poland, Romania, Mexico, Slovakia, Brazil
Novo Nordisk A/S

Completed

A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide, Insulin Degludec and Liraglutide in Japanese Subjects With Type 2 Diabetes Mellitus. (DUAL™ I Japan)

Diabetes Mellitus, Type 2 | Diabetes

Japan
University of Washington
Eli Lilly and Company; Sanofi; Bayer; US Department of Veterans Affairs; University... and other collaborators

Completed

FLuctuATion Reduction With inSULin and Glp-1 Added togetheR (FLAT-SUGAR) (FLAT-SUGAR)

Type 2 Diabetes

United States
The Cleveland Clinic

Completed

Residual Gastric Volume in Same Day Versus Split Dose and Evening Before Bowel Preparation

Colonoscopy | Esophagogastroduodenoscopy

United States
Taipei Medical University WanFang Hospital

Completed

Comparing Single-dose Low-volume PEG Plus Bisacodyl vs. Split-dose PEG for Bowel Preparation in Morning Colonoscopy

Bowel Preparation

Taiwan
Valduce Hospital
Istituti Ospitalieri di Cremona; Istituto Clinico Humanitas; Nuovo Regina Margherita...

Unknown

The Impact of Split Dose of Low-volume Polyethylene Glycol on Adenoma Detection Rate

Colonic Adenomas

Italy
HealthPartners Institute
Sanofi; International Diabetes Center at Park Nicollet

Completed

Continuous Glucose Monitoring Evaluation of Exenatide Twice Daily Versus Insulin Glargine

Type 2 Diabetes

United States
University of Basrah

Recruiting

Effect of Short-term Basal Insulin Initiation in Newly Diagnosed Type 2 Diabetes on 1-year Glycemic Control

Type2diabetes

Iraq
Sanofi

Completed

A Study to Evaluate the Effectiveness and Safety Initiation and Titration of Insulin Glargine (U300) in Insulin-naïve Patients With Type 2 Diabetes Mellitus (T2DM) Controlled on Oral Antidiabetic Drug Treatment in Turkey (EASE)

Type 2 Diabetes Mellitus

Turkey

3

Subscribe